Cytori Therapeutics releases schedule of fall 2010 and investor conferences

Cytori Therapeutics (NASDAQ:CYTX) announced today its fall 2010 conference schedule. The Company will be attending, presenting or exhibiting at the following U.S. meetings:

• September 23-26, 2010: Texas Society of Plastic Surgeons (Bastrop, TX): the trade show exhibition will feature the PureGraft™ System;
• October 1-4, 2010: American Society of Plastic Surgeons (ASPS - Toronto, Canada): the trade show exhibition will feature the Celution^® and PureGraft™ Systems; Dr. Scott Miller will present a comparison of the lipoaspirate quality between water-jet and syringe aspiration;
• October 1-3, 2010: World Congress of Liposuction Surgery (Washington D.C): Dr. Maurice Sherman will present on the importance of standardization of autologous fat grafts;
• October 15-16, 2010: First International Fat Grafting Forum (New Orleans, LA): Dr. Steve Cohen will give a presentation on new technologies for fat grafting, including the PureGraft™ System;
• October 22-24, 2010: IFATS 2010 (Dallas, TX): the trade show exhibition will feature the Celution^® and PureGraft™ Systems; Kevin Hicok, Cytori's Senior Manager of Research, will present on the standardization of analytical methods of autologous fat grafts;
• November 11-14, 2010: Florida Society of Plastic Surgeons (Walt Disney World, FL): the trade show exhibition will feature the PureGraft™ System;
• November 13-17, 2010: American Heart Association (Chicago, IL): Dr. Emerson Perin will be presenting the 6 month PRECISE chronic ischemia study results; Dr. Eric Duckers will be presenting a moderated poster on 6 month APOLLO heart attack study results.

In addition, Cytori will be presenting at two upcoming investor conferences:

• September 15, 2010: CL King's 8^th Annual Best Ideas Conference (New York, NY): Cytori's presentation at 2:15 PM ET will be webcast; the webcast can be located on the Investor Relations homepage;
• September 20, 2010: UBS Global Life Sciences Conference (New York, NY): Cytori's presentation at 11:00 AM ET will be webcast; the webcast can be located on the Investor Relations homepage.